Trametinib is a type of cancer medicine known as a kinase inhibitor. It works by blocking the action of certain proteins involved in cancer cell growth and survival. It is used to treat advanced melanoma (a type of skin cancer) that has spread to other parts of the body or cannot be removed by surgery. Trametinib is usually taken once daily as a pill. Common side effects include nausea, fatigue, and rash.
Trametinib is an anti-cancer medication used to treat various cancers with specific genetic mutations [1, 2]. Here's a breakdown of its key aspects:
Function:
- Targets and inhibits proteins involved in cancer cell growth and spread [1].
Cancers treated (often in combination with other drugs):
- Melanoma (a type of skin cancer) [1, 2].
- Non-small cell lung cancer (NSCLC) [1].
- Thyroid cancer [1].
- Certain types of solid tumors in adults and children [2].
- Specific types of glioma (brain tumor) in children [2].
How it works:
- Trametinib belongs to a class of drugs called MEK inhibitors [1].
- MEK proteins are part of a signaling pathway that promotes cancer cell growth and division [2].
- By inhibiting MEK, Trametinib helps slow down or stop the growth of cancer cells [2].
Important things to know about Trametinib:
- It's typically taken as a pill by mouth [1].
- Common side effects include rash, diarrhea, fatigue, swelling (especially in ankles and feet), nausea, and acne-like skin problems [2].
- Trametinib can weaken the immune system, making you more susceptible to infections [3].
- It can interact with other medications, so it's crucial to disclose all medications you take to your doctor before using Trametinib [3].
Anatomical Therapeutic Chemical Classification
L - Antineoplastic and immunomodulating agents
L01 Antineoplastic agents
L01E - Protein kinase inhibitors
L01EE Mitogen-activated protein kinase (MEK) inhibitors
ATC Code
External Links
Trametinib